Nutritional Support With TGF-β2 Food for Special Medical Purposes (TGF-β2 FSMP) in Adult Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for the Prevention of Malnutrition: a Prospective, Randomized, Multicenter Study
- Conditions
- Malnutrition (Calorie)Stem Cell Transplant Complications
- Registration Number
- NCT07010068
- Brief Summary
prospective, randomized, multicenter study to confirm the potential benefits of TGF-β2 enriched FSMP. The primary objective is to evaluate the superiority of supplementing with TGF-β2 FSMP (experimental arm) compared to best supportive treatment (BST) in preventing malnutrition in patients submitted to allo-SCT. The secondary endpoints include the assessment of reduction of incidence of severe acute GVHD at day +100.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 214
- Intact intestinal tract
- Life expectancy more than 12 weeks
- Allogeneic stem cell transplantation
- Signed informed consent
- Active hematological disease at the beginning of conditioning
- Personal history of inflammatory bowel diseases
- Personal history of bowel resection
- Personal history of gastric bypass procedures
- Enrolment in a competitive prospective study (malnutrition or GVHD as primary outcome)
- Subjects with known hypersensitivity to milk proteins or components of Modulen-IBD
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Prevention given from day -7 to day +28 ● PG-SGA score C (severe malnutrition) at day +28 \<50%
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.